Abstract
Not surprisingly, approximately half of the nearly 5 million people in the United States who have congestive heart failure (CHF) are women. Between 1985 and 1995, the number of hospitalizations for patients with heart failure increased from 1.7 to 2.6 million, and more than half of these patients were women. More than 500,000 new cases of CHF occur every year, and this disorder accounts for a major and ever-increasing number of hospitalizations. The aging population plays a significant role in this upswing. Improvements in survival, resulting from an array of new treatments, has resulted in more patients living longer with (often) more extensive disease. Thus, increasing the development of CHF in patients who previously would not have survived. Advances in the treatment of acute myocardial infarction, such as thrombolytic therapy and urgent angioplasty, have allowed more patients to survive what may have been a terminal event in the past. The aggressive use of hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in patients with coronary artery disease (CAD) and the treatment of lethal arrythmias with implantable defibrillators have also contributed to the growing number of patients with symptomatic CHF and left ventricular (LV) dysfunction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Braunwald E, Colucci WS. Pathophysiology of heart failure. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease. Saunders, Philadelphia, PA, 2001, p. 503.
Vasan RS, Levy D. Defining diastolic heart failure. A call for standardized diagnostic criteria. Circulation 2000; 101: 2118–2121.
The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741–751.
Davie AP, Francis CM, Caruana L, et al. The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure. Eur Heart J 1997; 18: 981–984.
Presti CF, Walling AD, Montemayor I, et al. Influence of exercise-induced myocardial ischemia on the pattern of left ventricular filling: a doppler echocardiographic study. J Am Coll Cardiol 1991; 18: 75–82.
Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: doppler echocardiography is the clinician’s Rosetta Stone. J Am Coll Cardiol 1997; 30: 8–18.
Garcia MJ, Thomas JD, Klein AL. New doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998; 32: 865–875.
Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22: 6A - 13A.
Kannel WB. Epidemiology and prevention of cardiac failure: Framingham Study insights. Eur Heart J 1987;8 Suppl F:23–26.
Marantz PR, Tobin JN, Wassertheil-Smoller S, et al. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 1988; 77: 607–612.
Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26: 1565–1574.
Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: A study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282–2289.
Ho KKL, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 1993; 88: 107–115.
Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol 1999; 33: 1948–1955.
Aronow WS, Ahn C, Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am J Cardi of 1990; 66: 1257–1259.
Wong WF, Gold S, Fukuyama O, Blanchette PL. Diastolic Dysfunction in elderly patients with congestive heart failure. Am J Cardiol 1989; 63: 1526–1528.
McDermott MM, Feinglass J, Sy J, Gheorghiade M. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy. Am J Med 1995; 99: 629–635.
McDermott MM, Feinglass J, Lee PI, et al. Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. Am Heart J 1997; 134: 728–736.
Judge KW, Pawitan Y, Caldwell J, et al. Congestive heart failure symptoms in patients with preserved left ventricular systolic function: analysis of the CASS registry. J Am Coll Cardiol 1991; 18: 377–383.
Phillbin EF, Rocco TA, Lindenmuth NW, et al. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000; 109: 605–613.
Senni M, Redfield MM. Heart failure with preserved systolic function. J Am Coll Cardiol 2001; 38: 1277–1282.
Vasan RS, Benjamin EJ, Levy D. Congestive heart failure with normal left ventricular systolic function: clinical approached to the diagnosis and treatment of diastolic heart failure. Arch Intern Med 1996; 156: 146–157.
Banerjee P, Banerjee T, Khand A, et al. Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol 2002; 39: 138–141.
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 2001; 38: 2101–2113.
Litwin SE, Grossman W. Diastolic dysfunction as a cause of heart failure. J Am Coll Cardiol I993;22[Supplement A] :49A–55A.
Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management. Ann Intern Med 1992; 117: 502–510.
Robinson K, Frenneaux MP, Stockins B, et al. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 1990; 15: 1279–1285.
Levy D, Larson MG, Ramachandran RS, et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557–1562.
Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 1993; 72: 310–313.
Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985; 312: 277–283.
Carroll JD, Carroll EP, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992; 86: 1099–1107.
Tofler GH, Stone PH, Muller JE, et al. and the MILIS study group. Effects of gender and race on prognosi after myocardial infarction: adverse prognosi for women, particularly black women. J Am Coll Cardiol 1987; 9: 473–482.
Mendes LA, Davidoff R, Cupples A, et al. Congestive heart failure in patients with coronary artery disease: the gender paradox. Am Heart J 1997; 134: 207–212.
Cohn JN, Johnson G, and the Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction: the V-HeFT study. Circulation 1990;81(Suppl III):III-48-III-53.
Ghali JK, Kadakia S, Bhatt A, et al. Survival of heart failure patients with preserved versus impaired systolic function: the prognostic implication of blood pressure. Am Heart J 1992; 123: 993–997.
Pernenkil R, Vinson JM, Shah AS, et al. Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 1997; 79: 216–219.
Setaro JF, Soufer R, Remetz MS, et al. Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol 1992; 69: 1212–1216.
Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301–306.
Adams KF, Dunlap SH, Sueta CA, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996; 28: 1781–1788.
Aronow WS, Kronzon I. Effects of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular function. Am J Cardiol 1993; 71: 602–604.
Warner JG, Metzger C, Kitzman DW, et al. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999; 33: 1567–1572.
Seatro J, Zaret BL, Schueman DS, et al. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular performance. Am J Cardiol 1990; 66: 981–986.
Aronow WS, Ahn C, Kronzon I. Effects of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. Am J Cardiol 1997; 80: 207–209.
The Digitalis Investigative Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525–533.
Lindenfeld J, Krausse-Steinrauf H, Salerno J. Where are all the women with heart failure? J Am Coll Cardiol 1997; 30: 1417–1419.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Walsh, M.N., Jessup, M. (2004). Diastolic Dysfunction in Women. In: Shaw, L.J., Redberg, R.F. (eds) Coronary Disease in Women. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-645-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-59259-645-4_7
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-275-9
Online ISBN: 978-1-59259-645-4
eBook Packages: Springer Book Archive